# Eckert & Ziegler and AtomVie sign global supply agreement for Lutetium-177

Eckert & Ziegler will supply its n.c.a. Lutetium-177 chloride (Theralugand®) to AtomVie Global Radiopharma for its CDMO activities in radiopharmaceutical manufacturing. The agreement covers early and late-stage development and global programs.

- Type: Contract
- Announced: 2025-03-20
- Status: announced
- Products: Lutetium-177 chloride (Theralugand®), radiopharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eckert & Ziegler](https://endata.com/companies/41023.md) (supplier)
- [AtomVie Global Radiopharma](https://endata.com/companies/83624.md) (customer)

## Sources

- [webdisclosure.com](https://www.webdisclosure.com/press-release/eckert-ziegler-strahlen-und-medizintechnik-ag-etr-euz-eckert-ziegler-and-atomvie-global-radiopharma-sign-a-global-agreement-for-lutetium-177-supply-xhnLpx7mYHI), 2025-03-20: "We are happy to support AtomVie in advancing global radiopharmaceutical development programs with Theralugand®."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.